Orgenesis Non Current Liabilities Total vs Short Term Investments Analysis

ORGS Stock

USD 0.47 0.05 9.62%

Orgenesis financial indicator trend analysis is much more than just breaking down Orgenesis prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orgenesis is a good investment. Please check the relationship between Orgenesis Non Current Liabilities Total and its Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.

Non Current Liabilities Total vs Short Term Investments

Non Current Liabilities Total vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orgenesis Non Current Liabilities Total account and Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Orgenesis' Non Current Liabilities Total and Short Term Investments is 0.49. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Orgenesis, assuming nothing else is changed. The correlation between historical values of Orgenesis' Non Current Liabilities Total and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Orgenesis are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Non Current Liabilities Total i.e., Orgenesis' Non Current Liabilities Total and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.49

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Non Current Liabilities Total

Short Term Investments

Short Term Investments is an item under the current assets section of Orgenesis balance sheet. It contains any investments Orgenesis undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Orgenesis can easily liquidate in the marketplace.

Most indicators from Orgenesis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orgenesis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.At this time, Orgenesis' Discontinued Operations is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 5.9 M in 2024, whereas Tax Provision is likely to drop (87.2 K) in 2024.

	2023	2024 (projected)
Reconciled Depreciation	1.7M	1.7M
Interest Income	31.5K	29.9K

Reconciled Depreciation Interest Income

Orgenesis fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Assets Total	Other Current Assets	Intangible Assets	Other Liab	Property Plant And Equipment Net	Non Currrent Assets Other	Other Assets	Net Receivables	Short Term Investments	Non Current Liabilities Total	Inventory
Total Assets		0.68	0.8	0.8	-0.04	-0.49	0.69	0.62	0.62	0.21	0.55	0.44	0.75	0.92	-0.36	0.79	0.5	0.18	0.02	0.68	0.82	0.44	0.6	0.65	0.58	0.49
Other Current Liab	0.68		0.77	0.38	0.52	-0.46	0.51	0.32	0.32	0.23	0.67	0.03	0.85	0.46	-0.34	0.58	0.23	0.18	0.14	0.49	0.46	0.13	0.22	0.76	0.76	0.83
Total Current Liabilities	0.8	0.77		0.46	0.16	-0.64	0.85	0.43	0.43	0.35	0.54	0.49	0.89	0.61	-0.2	0.74	0.51	0.2	0.25	0.48	0.5	0.37	0.35	0.87	0.64	0.45
Total Stockholder Equity	0.8	0.38	0.46		-0.3	-0.24	0.54	0.76	0.76	0.01	0.46	0.31	0.31	0.85	-0.32	0.53	0.16	0.11	-0.29	0.43	0.76	0.58	0.4	0.42	0.2	0.41
Net Debt	-0.04	0.52	0.16	-0.3		-0.26	-0.07	-0.49	-0.49	-0.28	0.47	-0.22	0.27	-0.24	0.03	-0.04	0.1	-0.13	0.07	0.12	-0.15	-0.01	0.12	0.27	0.27	0.3
Retained Earnings	-0.49	-0.46	-0.64	-0.24	-0.26		-0.76	-0.26	-0.26	0.13	-0.77	-0.81	-0.49	-0.52	0.34	-0.34	-0.8	0.27	0.17	-0.35	-0.47	-0.52	-0.5	-0.55	-0.29	-0.04
Accounts Payable	0.69	0.51	0.85	0.54	-0.07	-0.76		0.66	0.66	0.01	0.63	0.68	0.64	0.67	-0.14	0.53	0.56	0.0	0.03	0.31	0.45	0.48	0.25	0.73	0.38	0.18
Cash	0.62	0.32	0.43	0.76	-0.49	-0.26	0.66		1.0	0.03	0.41	0.27	0.36	0.76	-0.32	0.32	0.09	0.11	-0.08	0.17	0.52	0.27	0.01	0.39	0.27	0.35
Cash And Short Term Investments	0.62	0.32	0.43	0.76	-0.49	-0.26	0.66	1.0		0.03	0.41	0.27	0.36	0.76	-0.32	0.32	0.09	0.11	-0.08	0.17	0.52	0.27	0.01	0.39	0.27	0.35
Common Stock Total Equity	0.21	0.23	0.35	0.01	-0.28	0.13	0.01	0.03	0.03		-0.27	0.04	0.41	0.03	-0.27	0.36	0.0	0.31	0.39	0.04	0.25	-0.16	0.0	0.2	0.28	0.33
Common Stock Shares Outstanding	0.55	0.67	0.54	0.46	0.47	-0.77	0.63	0.41	0.41	-0.27		0.41	0.48	0.55	-0.39	0.16	0.45	-0.26	-0.22	0.19	0.51	0.51	0.35	0.59	0.27	0.42
Other Stockholder Equity	0.44	0.03	0.49	0.31	-0.22	-0.81	0.68	0.27	0.27	0.04	0.41		0.21	0.54	-0.19	0.33	0.85	-0.25	-0.19	0.24	0.53	0.56	0.61	0.34	-0.05	-0.32
Total Liab	0.75	0.85	0.89	0.31	0.27	-0.49	0.64	0.36	0.36	0.41	0.48	0.21		0.53	-0.28	0.7	0.36	0.27	0.41	0.51	0.45	0.16	0.23	0.74	0.86	0.64
Total Current Assets	0.92	0.46	0.61	0.85	-0.24	-0.52	0.67	0.76	0.76	0.03	0.55	0.54	0.53		-0.4	0.62	0.54	0.06	-0.13	0.59	0.85	0.47	0.63	0.5	0.39	0.3
Common Stock	-0.36	-0.34	-0.2	-0.32	0.03	0.34	-0.14	-0.32	-0.32	-0.27	-0.39	-0.19	-0.28	-0.4		-0.2	-0.15	0.22	0.22	-0.26	-0.41	-0.27	-0.19	-0.08	-0.28	-0.36
Non Current Assets Total	0.79	0.58	0.74	0.53	-0.04	-0.34	0.53	0.32	0.32	0.36	0.16	0.33	0.7	0.62	-0.2		0.39	0.24	0.15	0.88	0.57	0.29	0.47	0.53	0.74	0.41
Other Current Assets	0.5	0.23	0.51	0.16	0.1	-0.8	0.56	0.09	0.09	0.0	0.45	0.85	0.36	0.54	-0.15	0.39		-0.28	0.0	0.41	0.55	0.29	0.8	0.38	0.13	-0.25
Intangible Assets	0.18	0.18	0.2	0.11	-0.13	0.27	0.0	0.11	0.11	0.31	-0.26	-0.25	0.27	0.06	0.22	0.24	-0.28		0.23	0.11	-0.01	-0.11	-0.16	0.21	0.27	0.3
Other Liab	0.02	0.14	0.25	-0.29	0.07	0.17	0.03	-0.08	-0.08	0.39	-0.22	-0.19	0.41	-0.13	0.22	0.15	0.0	0.23		-0.05	-0.16	-0.18	-0.11	0.19	0.36	-0.01
Property Plant And Equipment Net	0.68	0.49	0.48	0.43	0.12	-0.35	0.31	0.17	0.17	0.04	0.19	0.24	0.51	0.59	-0.26	0.88	0.41	0.11	-0.05		0.54	0.24	0.58	0.32	0.71	0.32
Non Currrent Assets Other	0.82	0.46	0.5	0.76	-0.15	-0.47	0.45	0.52	0.52	0.25	0.51	0.53	0.45	0.85	-0.41	0.57	0.55	-0.01	-0.16	0.54		0.46	0.75	0.44	0.31	0.39
Other Assets	0.44	0.13	0.37	0.58	-0.01	-0.52	0.48	0.27	0.27	-0.16	0.51	0.56	0.16	0.47	-0.27	0.29	0.29	-0.11	-0.18	0.24	0.46		0.41	0.33	0.01	0.0
Net Receivables	0.6	0.22	0.35	0.4	0.12	-0.5	0.25	0.01	0.01	0.0	0.35	0.61	0.23	0.63	-0.19	0.47	0.8	-0.16	-0.11	0.58	0.75	0.41		0.27	0.09	-0.08
Short Term Investments	0.65	0.76	0.87	0.42	0.27	-0.55	0.73	0.39	0.39	0.2	0.59	0.34	0.74	0.5	-0.08	0.53	0.38	0.21	0.19	0.32	0.44	0.33	0.27		0.49	0.52
Non Current Liabilities Total	0.58	0.76	0.64	0.2	0.27	-0.29	0.38	0.27	0.27	0.28	0.27	-0.05	0.86	0.39	-0.28	0.74	0.13	0.27	0.36	0.71	0.31	0.01	0.09	0.49		0.67
Inventory	0.49	0.83	0.45	0.41	0.3	-0.04	0.18	0.35	0.35	0.33	0.42	-0.32	0.64	0.3	-0.36	0.41	-0.25	0.3	-0.01	0.32	0.39	0.0	-0.08	0.52	0.67

Click cells to compare fundamentals

Orgenesis Account Relationship Matchups

Orgenesis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	73.9M	77.7M	59.8M	90.9M	14.6M	38.8M
Other Current Liab	6.8M	2.3M	2.4M	4.7M	4.1M	7.1M
Total Current Liabilities	17.2M	16.3M	15.4M	15.9M	16.4M	11.9M
Total Stockholder Equity	26.1M	52.6M	38.5M	27.6M	(21.0M)	27.4M
Net Debt	(32.0M)	6.4M	15.0M	21.8M	25.1M	26.3M
Retained Earnings	(65.2M)	(88.3M)	(106.4M)	(121.3M)	(176.6M)	(68.4M)
Accounts Payable	4.6M	8.6M	5.2M	4.4M	6.6M	3.7M
Cash	14.6M	44.9M	5.5M	5.3M	837K	15.3M
Cash And Short Term Investments	14.6M	44.9M	5.5M	5.3M	837K	15.3M
Common Stock Shares Outstanding	21.3M	24.3M	25.1M	29.0M	33.4M	35.0M
Liabilities And Stockholders Equity	77.7M	59.8M	90.9M	14.6M	16.7M	15.9M
Other Stockholder Equity	669K	140.1M	144.7M	149.1M	155.6M	635.6K
Total Liab	47.8M	25.0M	21.2M	31.7M	35.5M	25.6M
Total Current Assets	28.1M	50.1M	25.8M	46.3M	4.1M	15.1M
Non Current Assets Total	27.6M	34.1M	44.6M	10.5M	12.0M	11.4M
Other Current Assets	387K	1.7M	1.7M	4.7M	3.1M	367.7K
Intangible Assets	16.6M	13.0M	11.8M	9.7M	7.4M	9.9M
Other Liab	2.2M	387K	389K	578K	2.0M	2.5M
Property Plant And Equipment Net	4.5M	11.3M	25.1M	1.8M	2.1M	2.0M
Non Currrent Assets Other	440K	821K	805K	1.4M	18K	708.5K
Other Assets	1.3M	1.5M	2.8M	8.6M	1.7M	1.8M
Net Receivables	3.2M	3.3M	18.5M	39.8M	2.6M	3.1M
Non Current Liabilities Total	8.7M	5.8M	15.7M	19.1M	22.0M	16.6M
Inventory	1.7M	185K	118K	120K	34K	1.7M
Property Plant And Equipment Gross	12.5M	4.5M	11.3M	29.1M	2.4M	10.1M
Property Plant Equipment	11.9M	12.5M	4.3M	5.1M	14.3M	15.0M
Short Long Term Debt Total	4.8M	12.9M	11.8M	20.3M	22.6M	4.5M
Accumulated Other Comprehensive Income	1M	748K	207K	(270K)	65K	1.1M
Short Term Debt	753K	4.6M	6.4M	5.1M	3.6M	715.4K
Net Tangible Assets	(5.8M)	30.8M	18.3M	9.7M	(6.7M)	(6.3M)
Current Deferred Revenue	751K	1.3M	1.6M	2.2M	2.5M	3.6M
Short Long Term Debt	753K	4.1M	5.9M	4.5M	3.3M	715.4K
Long Term Debt	2.8M	7.3M	4.9M	13.3M	19.0M	2.7M
Good Will	15.3M	8.7M	8.4M	8.2M	1.2M	8.1M

Pair Trading with Orgenesis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orgenesis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will appreciate offsetting losses from the drop in the long position's value.

Moving together with Orgenesis Stock

0.75

ENVB

Enveric Biosciences

Pair Corr

Moving against Orgenesis Stock

0.61	AZN	AstraZeneca PLC ADR	Pair Corr
0.61	SLS	Sellas Life Sciences	Pair Corr
0.6	MRK	Merck Company Financial Report 6th of August 2024	Pair Corr
0.53	PTN	Palatin Technologies Fiscal Year End 26th of September 2024	Pair Corr
0.5	VALN	Valneva SE ADR	Pair Corr

The ability to find closely correlated positions to Orgenesis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orgenesis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orgenesis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orgenesis to buy it.

The correlation of Orgenesis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orgenesis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orgenesis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Orgenesis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Orgenesis Stock Analysis

When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC